Clopidogrel and Depakote drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Clopidogrel (clopidogrel) and Depakote (divalproex sodium). Common drug interactions include renal failure acute among females and asthenia among males.
The phase IV clinical study analyzes what interactions people have when they take Clopidogrel and Depakote. It is created by eHealthMe based on reports of 99 people who take the same drugs from the FDA, and is updated regularly.
What is Clopidogrel?
Clopidogrel has active ingredients of clopidogrel. It is often used in blood clots. eHealthMe is studying from 92,160 Clopidogrel users. Check the latest studies of Clopidogrel.
What is Depakote?
Depakote has active ingredients of divalproex sodium. It is often used in bipolar disorder. eHealthMe is studying from 55,581 Depakote users. Check the latest studies of Depakote.
99 people who take Clopidogrel and Depakote together, and have interactions are studied.

What are the common drug interactions of Clopidogrel and Depakote, by gender? *:
female:
- Renal failure acute (rapid kidney dysfunction)
- Vertigo
- Pain in extremity
- Arterial thrombosis (formation of a blood clot inside a blood vessel, obstructing the flow of blood through the circulatory system)
- Atrioventricular block complete (heart block complete)
- Cerebral haemorrhage (bleeding within the brain)
- Dysarthria (speech disorder)
- Erosive oesophagitis (acid reflux disease can cause tissue damage in the oesophagus over time)
- Hemiparesis (weakness on one side of the body)
- Hypotension (abnormally low blood pressure)
male:
- Asthenia (weakness)
- Dizziness
- Pneumonia
- Tremor (trembling or shaking movements in one or more parts of your body)
- Blood glucose fluctuation
- Cardiac failure
- Chronic kidney disease
- Contusion (a type of hematoma of tissue in which capillaries)
- Depression
- Dyskinesia (abnormality or impairment of voluntary movement)
What are the common drug interactions of Clopidogrel and Depakote, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
n/a
30-39:
- Abdominal pain
- Alcohol abuse
- Arteriosclerosis (thickening and hardening of arteries)
- Asthenia (weakness)
- Borderline personality disorder
- Chest pain
- Cholecystitis (infection of gallbladder)
- Death
- Dependent personality disorder
- Dermatitis contact (skin reaction (dermatitis) resulting from exposure to allergens)
40-49:
- Suicidal ideation
- Diabetes mellitus (diabetes, caused by a deficiency of the pancreatic hormone insulin)
- Nervous system disorder (a general class of medical conditions affecting the nervous system)
- Chronic kidney disease
- Gait disturbance
- Hemiplegia (paralysis of one side of the body)
- Hyperglycaemia (high blood sugar)
- Ill-defined disorder
- Joint swelling
- Pain in extremity
50-59:
- Cardiac arrest
- Cardiomyopathy (weakening of the heart muscle)
- Chest pain
- Cholecystitis (infection of gallbladder)
- Chronic kidney disease
- Confusional state
- Coronary artery occlusion (complete obstruction of blood flow in a coronary artery)
- Diabetes mellitus (diabetes, caused by a deficiency of the pancreatic hormone insulin)
- Disturbance in social behaviour
- Drug ineffective
60+:
- Chronic kidney disease
- Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body)
- Atelectasis (partial or complete collapse of the lung)
- Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
- Cardiac arrest
- Gastric ulcer (stomach ulcer)
- Gastrointestinal haemorrhage (bleeding gastrointestinal tract)
- Injury
- Oropharyngeal pain
- Polycythaemia (proportion of blood volume that is occupied by red blood cells increases)
What are the existing conditions these people have? *
- High Blood Pressure: 21 people, 21.21%
- High Blood Cholesterol: 18 people, 18.18%
- Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 15 people, 15.15%
- Pain: 12 people, 12.12%
- Seizures (abnormal excessive or synchronous neuronal activity in the brain): 8 people, 8.08%
- Insomnia (sleeplessness): 8 people, 8.08%
- Depression: 8 people, 8.08%
- Infection: 7 people, 7.07%
- Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 7 people, 7.07%
- Acne (skin problems that cause pimples): 6 people, 6.06%
* Approximation only. Some reports may have incomplete information.
Do you take Clopidogrel and Depakote?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
- Clopidogrel (92,160 reports)
- Depakote (55,581 reports)
Browse all drug interactions of Clopidogrel and Depakote:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Clopidogrel:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Depakote:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Clopidogrel and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Depakote and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zRelated publications that referenced our studies
- Lai SW, Lin CL, Liao KF, "Actively using clopidogrel correlates with an increased risk of acute pancreatitis in Taiwan", International journal of cardiology, 2015 Mar .
- Jacob S, Dunn BL, Qureshi ZP, Bandarenko N, Kwaan HC, Pandey DK, McKoy JM, Barnato SE, Winters JL, Cursio JF, Weiss I, "Ticlopidine-, clopidogrel-, and prasugrel-associated thrombotic thrombocytopenic purpura: a 20-year review from the Southern Network on Adverse Reactions (SONAR)", InSeminars in thrombosis and hemostasis, 2012 Jan .
- Frank P, "Ticlopidine-, Clopidogrel-, and Prasugrel-Associated Thrombotic Thrombocytopenic Purpura: A Twenty-Year Review from the Southern Network on Adverse Reactions (SONAR)", , 2012 Jan .
- Lai SW, Lin CL, Liao KF, "Actively using clopidogrel correlates with an increased risk of acute pancreatitis in Taiwan", International journal of cardiology, 2015 Mar .
- Jacob S, Dunn BL, Qureshi ZP, Bandarenko N, Kwaan HC, Pandey DK, McKoy JM, Barnato SE, Winters JL, Cursio JF, Weiss I, "Ticlopidine-, clopidogrel-, and prasugrel-associated thrombotic thrombocytopenic purpura: a 20-year review from the Southern Network on Adverse Reactions (SONAR)", InSeminars in thrombosis and hemostasis, 2012 Jan .
- Frank P, "Ticlopidine-, Clopidogrel-, and Prasugrel-Associated Thrombotic Thrombocytopenic Purpura: A Twenty-Year Review from the Southern Network on Adverse Reactions (SONAR)", , 2012 Jan .
How the study uses the data?
The study uses data from the FDA. It is based on clopidogrel and divalproex sodium (the active ingredients of Clopidogrel and Depakote, respectively), and Clopidogrel and Depakote (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Drug interactions of Dexilant and Imvexxy - 3 seconds ago
- Could Magnesium Sulfate cause Renal Injury? - 13 seconds ago
- Could Neoral cause Tonsillitis? - 17 seconds ago
- Could Levophed cause Blood Glucose Increased? - 25 seconds ago
- Drug interactions of Melphalan and Keflex - 28 seconds ago
- Could Strattera cause Post Procedural Complication? - 29 seconds ago
- Gait Disturbance and Lower Respiratory Tract Infection - 30 seconds ago
- Drug interactions of Esomeprazole Sodium and Azathioprine - 34 seconds ago
- Drug interactions of Melphalan Hydrochloride and Ultracet - 35 seconds ago
- Focal Segmental Glomerulosclerosis and Confusional State - 37 seconds ago